NPPA and Candidemia: In contrast, the KPC-Kp susceptibility pattern, history of previous ceftazidime/avibactam treatment, the onset of concomitant and/or superimposed candidemia, and developing a KPC-Kp infection relapse presented a non-negligible yet much more modest role in predicting patient mortality.